机构:[1]Department of Cardiology, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, No. 16, Xiantong Road, Liantang Street, Luohu District, Shenzhen 518004, Guangdong, People’s Republic of China深圳市康宁医院深圳医学信息中心[2]Department of Encephalopathy, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shenzhen 518004, People’s Republic of China深圳市康宁医院深圳医学信息中心
This study was funded by Basic research in Bao'an District,
Shenzhen in 2021 (medical and health) (No. 2021JD301), Scientifc
Research Project of Guangdong Administration of Traditional Chinese
Medicine (No. 20222197), and The research Project of Luohu District
soft science (No. LX202202041)
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区生物学
小类|4 区细胞生物学
最新[2025]版:
大类|3 区生物学
小类|4 区细胞生物学
第一作者:
第一作者机构:[1]Department of Cardiology, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, No. 16, Xiantong Road, Liantang Street, Luohu District, Shenzhen 518004, Guangdong, People’s Republic of China
通讯作者:
推荐引用方式(GB/T 7714):
Huangfu Haiquan,Huang Zhichao,Liao Weiqian,et al.M1 linear ubiquitination of LKB1 inhibits vascular endothelial cell injury in atherosclerosis through activation of AMPK[J].Human cell.2023,doi:10.1007/s13577-023-00950-2.
APA:
Huangfu Haiquan,Huang Zhichao,Liao Weiqian,Zou Tianyu,Shang Xiaoming&Yu Hairui.(2023).M1 linear ubiquitination of LKB1 inhibits vascular endothelial cell injury in atherosclerosis through activation of AMPK.Human cell,,
MLA:
Huangfu Haiquan,et al."M1 linear ubiquitination of LKB1 inhibits vascular endothelial cell injury in atherosclerosis through activation of AMPK".Human cell .(2023)